# A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

> **NCT00545207** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 150 (actual)

## Conditions studied

- Post-Menopausal Osteopenia

## Interventions

- **DRUG:** ibandronate [Bonviva/Boniva]
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00545207
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545207, "A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00545207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*